Veeva DQS Cleans Data for More Than 1 Million Subjects Across Over 1,000 Studies

Automates data reconciliation, saving clinical teams significant cost, time, and effort

BARCELONA, Spain, Oct. 6, 2026 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that Veeva DQS (Data Quality System) has aggregated and cleaned data for more than 1 million subjects in more than 1,000 studies to accelerate the delivery of analysis-ready data and trial insights. With more than 500,000 automated queries, Veeva DQS has saved thousands of hours in data reconciliation for sites and sponsors.

"One key area for us is handling the increasing volume of data generated from our growing number of clinical trials," said Ibrahim Kamstrup-Akkaoui, vice president at Novo. "Veeva DQS can help us manage, format, clean, and prepare this data for submission more efficiently."

Veeva DQS enables next-generation clinical data management with advancements essential for adopting the risk-based strategies recommended in regulatory guidelines, including ICH E6(R3). With innovations coming in Veeva DQS, clinical teams can:

- Gain high-quality data faster: Veeva DQS automates data workflows, classifies and visualizes critical data, and drives the orchestration of risk-based actions across the clinical ecosystem while eliminating manual data reconciliation.

- Enable risk-based quality management (RBQM): Automated data exchange between Veeva DQS and Veeva CTMS streamlines risk-based monitoring by instantly alerting clinical operations teams to key data changes, like protocol deviations, and allowing clinical data teams to calculate, track, and action key risk indicators (KRIs).

- Classify with data- and user-aware AI: Veeva DQS embeds AI to speed up the classification of study data and understand its purpose and criticality. This allows the system to generate items, like reports, listings, or test scripts, and deliver custom user experiences and workflows based on role.

"With increasing data sources and growing protocol complexity, sponsors and CROs are using Veeva DQS to automate data workflows at scale across studies of all sizes," said Pavel Burmenko, lead, Veeva DQS strategy. "Veeva DQS is ushering in next-generation data management, a new level of clinical data innovation that orchestrates risk-based reviews and elevates the role of data managers toward strategic partners."

Recently announced, Veeva Study Builder Agent configures Veeva EDC and Veeva DQS directly from a study protocol for faster and more consistent study builds. Learn more about Study Builder Agent, the SCDM Innovation Award winning Veeva DQS, and how biopharmas are driving clinical data innovation at Veeva R&D and Quality Summit, Oct. 20-21 in Boston. The event is open exclusively to life sciences industry professionals.

About Veeva Systems

Veeva delivers the industry cloud for life sciences with applications, agents, data, and consulting. Committed to innovation, product excellence, and customer success, Veeva serves more than 1,500 customers, ranging from the world's largest pharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit veeva.com/eu.

Veeva Forward-Looking Statements

This release contains forward-looking statements regarding Veeva's products and services and the expected results or benefits from use of our products and services. These statements are based on our current expectations. Actual results could differ materially from those provided in this release and we have no obligation to update such statements. There are numerous risks that have the potential to negatively impact our results, including the risks and uncertainties disclosed in our filing on Form 10-Q for the fiscal year ended July 31, 2026, which you can find here (a summary of risks which may impact our business can be found on pages 33 and 34), and in our subsequent SEC filings, which you can access at sec.gov.

Contact:

Jeremy Whittaker

Veeva Systems

+49-695-095-5486

[email protected]

Share this article

TORONTO, Oct. 6, 2026 /PRNewswire/ -- Aclara Resources Inc. ("Aclara" or the "Company") (TSX: ARA) is pleased to announce it is expanding the scope of Project Dynamo, its planned rare earth separation facility in Louisiana, to incorporate separation capabilities for yttrium ("Y"), gadolinium ("Gd") and samarium ("Sm"), in addition to the previously planned production of neodymium-praseodymium ("NdPr"), dysprosium ("Dy") and terbium ("Tb").

As the first stage of this expansion, Aclara, through its wholly-owned subsidiary Aclara Technologies Inc., has commenced the installation of additional solvent extraction ("SX") circuits at its rare earth separation demonstration plant located at Virginia Tech Corporate Research Center in Blacksburg, Virginia. The new circuits are being designed to demonstrate the separation of Y, Gd and Sm using feedstock representative of the Super-Pure Rare Earth Carbonate ("SPREC") expected to be produced from Aclara's ionic clay deposits in Chile and Brazil.

Work at the demonstration plant is already underway. Equipment for the new Y separation circuit has arrived at the Virginia Tech facility and is expected to be installed and commissioned over the coming weeks, with Gd and Sm circuits expected to follow.

To support the expanded program, Aclara has doubled the physical footprint of its demonstration plant and is planning to approximately double the number of technical personnel supporting the facility.

Ramon Barua, Chief Executive Officer of Aclara, commented:

"The expansion of Project Dynamo represents an important advancement of Aclara's strategy. In addition to building a supply chain for the rare earths required for permanent magnets, we are expanding into materials that are becoming critical to power generation, aerospace applications -including aircraft jet engines- and the infrastructure supporting artificial intelligence."

"Yttrium is a particularly compelling opportunity. Approximately 50% of the rare earth composition of our Penco Project and 30% of our Carina Project is yttrium, giving Aclara a differentiated resource position in a market where Western supply remains highly dependent on imports. Penco has received its environmental approval and is positioned to advance toward construction, subject to securing the required financing."

"The rapid growth of AI and data centers is driving significant investment in power generation infrastructure, including gas turbines, where yttrium plays an important role in high-temperature applications. By combining our resource base with separation capabilities in the United States, we believe Aclara can become an important supplier into these strategic markets."

Expanding Project Dynamo

Project Dynamo was originally designed to separate NdPr, Dy and Tb. The planned expansion will add dedicated separation capabilities for Y, Gd and Sm, broadening the range of high-purity rare earth products Aclara intends to produce in the United States.

To incorporate the expanded product scope, Aclara is modifying the basic engineering of Project Dynamo to include the additional separation circuits in the industrial-scale facility in Louisiana. As part of this expansion, the number of mixer-settlers in the solvent extraction process is expected to increase from approximately 340 to 478, representing a significant expansion of the plant's separation capacity and complexity.

The expansion is expected to create two complementary rare earth platforms:

- Magnetic rare earths: NdPr, Dy, Tb and Sm, serving applications including e-mobility and robotics;

- Non-magnetic rare earths: Y and Gd, serving applications across power generation, aerospace applications -including aircraft jet engines- and other high-performance technologies.

Project Dynamo has secured its State Air Permit from the Louisiana Department of Environmental Quality, and basic engineering for the facility is in its final stages. Aclara is targeting groundbreaking in the first quarter of 2027, subject to securing the required financing.

Yttrium: A Strategic Growth Opportunity

Aclara believes yttrium represents a significant new growth opportunity.

The rapid expansion of AI and cloud infrastructure is driving substantial investment in data centers and associated power generation capacity. Gas turbines are expected to play an important role in supporting this growth, and yttrium is used in advanced high-temperature materials required in turbine applications.

Aclara believes it is particularly well positioned because yttrium represents a significant component of its ionic clay resource base. Based on the current technical reports for the Carina Project and Penco Module, Aclara expects its mineral projects to have the potential to produce SPREC containing approximately 1,400 tonnes of yttrium per year at full production.

The Company is engaged in preliminary discussions with potential customers regarding future supply of yttrium and other rare earth products from Project Dynamo; no definitive offtake agreement have been entered into.

Collaboration with Virginia Tech and Argonne National Laboratory

Aclara's U.S. separation development program combines the Company's proprietary rare earth processing technology with the capabilities of Virginia Tech and Argonne National Laboratory ("Argonne").

Virginia Tech hosts Aclara's demonstration plant in Blacksburg, where operating data is generated to demonstrate and optimize the Company's separation process ahead of commercial-scale deployment at Project Dynamo.

The collaboration with Virginia Tech is also an important component of Aclara's workforce development strategy. Rebuilding rare earth industrialization and processing capabilities in the United States will require experienced engineers, chemists and plant operators with direct operating experience in rare earth separation.

Aclara is using the demonstration plant as a training platform for the technical workforce that will ultimately support Project Dynamo. Engineers, chemists and operators are expected to gain up to two years of hands-on operating experience at the Virginia Tech facility before the Louisiana plant enters production, which Aclara expects to provide a trained and experienced workforce to support a faster and lower-risk ramp-up of the commercial facility.

Aclara is also collaborating with Argonne under a Cooperative Research and Development Agreement to develop an AI-enabled digital twin of the separation process using operational data from the Virginia Tech facility and Argonne's SolventX modeling platform.

Together, the Virginia Tech and Argonne collaborations are designed to support both the technical optimization of the process and the development of the people and operating capabilities required to scale rare earth separation in the United States.

About Aclara

Aclara Resources Inc. (TSX: ARA), a Toronto Stock Exchange listed company, is focused on building a vertically integrated supply chain for rare earth alloys used in permanent magnets, as well as high-purity rare earth oxides, including yttrium and gadolinium, for power generation, aerospace and other high-performance applications. This strategy is supported by Aclara's development of rare earth mineral resources hosted in ionic clay deposits, which contain high concentrations of the scarce heavy rare earths, providing the Company with a long-term, reliable source of these critical materials. The Company's rare earth mineral resource development projects include the Carina Project in the State of Goiás, Brazil as its flagship project and the Penco Module in the Biobío Region of Chile. Both projects feature Aclara's patented technology named Circular Mineral Harvesting, which offers a sustainable and energy-efficient extraction process for rare earths from ionic clay deposits. The Circular Mineral Harvesting process has been designed to minimize the water consumption and overall environmental impact through recycling and circular economy principles. Through its wholly-owned subsidiary, Aclara Technologies Inc., the Company is further enhancing its product value by developing a rare earth separation plant in the United States. This facility will process mixed rare earth carbonates sourced from Aclara's mineral resource projects, separating them into pure individual rare earth oxides. Additionally, Aclara through a joint venture with CAP, is advancing its alloy-making capabilities to convert these refined oxides into the alloys needed for fabricating permanent magnets. This joint venture leverages CAP's extensive expertise in metal refining and special ferro-alloyed steels. Beyond the Carina Project and the Penco Module, Aclara is committed to expanding its mineral resource portfolio by exploring greenfield opportunities and further developing projects within its existing concessions in Brazil, Chile, and Peru, aiming to increase future production of heavy rare earths.

Study to Explore Oral Maintenance Dosing Regimens Following Initial Weight Loss with Subcutaneous VK2735

Monthly and Every-Other-Week Subcutaneous Regimens to also be Evaluated

SAN DIEGO, Oct. 6, 2026 /PRNewswire/ -- Viking Therapeutics, Inc. (Viking) (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced the initiation of an exploratory oral maintenance dosing study of VK2735, the company's dual agonist of the glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors. VK2375 is being developed in both oral and subcutaneous formulations for the potential treatment of various metabolic disorders such as obesity. The trial announced today is the second in a two-part maintenance study initiated in 2025. Positive top-line results were recently announced from Part 1 of this study, which evaluated various subcutaneous dosing regimens for their potential to maintain the initial weight loss achieved with weekly subcutaneous dosing. Part 2 of the study is designed to explore the potential of various VK2735 oral tablet dosing regimens as well as additional subcutaneous dosing regimens to maintain the initial weight loss achieved from weekly subcutaneous dosing.

The maintenance dosing study is a randomized, double-blind, placebo-controlled trial in approximately 195 adults with obesity (BMI ≥30 kg/m2) who are otherwise healthy. As in Part 1 of the study, all participants will receive initial weekly subcutaneous doses of VK2735 or placebo for 21 weeks. Following Week 21, participants will transition to a range of VK2735 maintenance dosing options including daily oral doses, weekly oral doses, monthly subcutaneous doses, every-other-week subcutaneous doses, or placebo. The study objectives are to evaluate the safety, tolerability, and pharmacokinetic profile of VK2735 under these various dosing regimens. Exploratory endpoints will assess changes in body weight from baseline and from Week 21 to the end of the study at Week 33.

"Our recent top-line results from Part 1 of this study demonstrated the potency and differentiated profile of VK2735 in the setting of both weight loss induction and potentially longer-term maintenance. We are eager to continue this study with the initiation of Part 2, which will explore multiple regimens, both oral and subcutaneous, with the potential to provide greater optionality and flexibility to best align with a patient's individual weight loss journey," said Brian Lian, Ph.D., chief executive officer of Viking. "Adherence to therapy is critical to achieving the long-term benefits of weight loss, including reduction of cardiovascular risk, improved physical function, and enhanced quality of life. We believe flexibility and optionality are key to increasing adherence to treatment and improving long-term weight management - from induction to maintenance. We were pleased to report positive results from our recent subcutaneous maintenance study and are excited by the potential to validate additional maintenance regimens as well. In doing so, we expect to offer patients and their clinicians a broad range of highly effective and convenient tools to achieve personalized weight loss goals. We look forward to reporting the results from Part 2 of this study in 2027."

In addition to the maintenance dosing study, Viking is currently conducting two Phase 3 studies evaluating subcutaneous VK2735 (VANQUISH-1 and VANQUISH-2). These trials are randomized, double-blind, placebo-controlled, multicenter trials designed to assess the efficacy and safety of subcutaneous VK2735 dosed weekly for 78 weeks. The VANQUISH-1 study is fully enrolled with approximately 4,500 adults who do not have type 2 diabetes and who have obesity (BMI ≥30 kg/m2) or are overweight (BMI ≥27 kg/m2) with at least one weight-related co-morbid condition. The VANQUISH-2 study is also fully enrolled with approximately 1,000 adults with type 2 diabetes who have obesity or are overweight. Patients in both trials are being randomized to one of four weekly treatment arms: VK2735 7.5 mg; VK2735 12.5 mg; VK2735 17.5 mg; and placebo.

About GLP-1 and Dual GLP-1/GIP Agonists

Activation of the glucagon-like peptide 1 (GLP-1) receptor has been shown to decrease glucose, reduce appetite, lower body weight, and improve insulin sensitivity in patients with type 2 diabetes, obesity, or both. Semaglutide is a GLP-1 receptor agonist that has been approved by the U.S. Food and Drug Administration and is currently marketed in various dosage strengths and forms as Ozempic®, Rybelsus®, and Wegovy®. More recently, research efforts have explored the potential co-activation of the glucose-dependent insulinotropic peptide (GIP) receptor as a means of enhancing the therapeutic benefits of GLP-1 receptor activation. Tirzepatide is a dual GLP-1/GIP receptor agonist that has been approved by the U.S. Food and Drug Administration and is currently marketed in various dosage strengths and forms as Mounjaro® and Zepbound®.

About Viking Therapeutics, Inc.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company advancing a next-generation portfolio of therapies for obesity and metabolic disease. Guided by deep expertise in metabolic biology and rigorous science, Viking is developing innovative treatments to help people achieve meaningful, lasting health improvements by treating obesity first. The company's lead program, VK2735, is a dual glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptor agonist in development in both subcutaneous and oral formulations for obesity. VK2735 is currently being evaluated in Phase 3 clinical studies for obesity, along with maintenance dosing strategies designed to support long-term weight management. Viking is also advancing additional obesity programs, including VK3019, an amylin receptor agonist, VK2809, an orally available thyroid hormone receptor beta agonist for metabolic and liver disease, and VK0214 for the rare genetic disorder X-linked adrenoleukodystrophy (X-ALD).

For more information about Viking Therapeutics, please visit www.vikingtherapeutics.com.

Forward-Looking Statements

This press release contains forward-looking statements regarding Viking Therapeutics, Inc., under the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, including statements about Viking's expectations regarding its clinical and preclinical development programs, anticipated timing for reporting clinical data and cash resources. Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially and adversely and reported results should not be considered as an indication of future performance.These risks and uncertainties include, but are not limited to: risks associated with the success, cost and timing of Viking's product candidate development activities and clinical trials, including those for VK2735, VK0214, VK2809, and the company's other incretin receptor agonists; risks that prior clinical and preclinical results may not be replicated; risks regarding regulatory requirements; and other risks that are described in Viking's most recent periodic reports filed with the Securities and Exchange Commission, including Viking's Annual Report on Form 10-K for the year ended December 31, 2024, and subsequent Quarterly Reports on Form 10-Q, including the risk factors set forth in those filings.These forward-looking statements speak only as of the date hereof.Viking disclaims any obligation to update these forward-looking statements except as required by law.

SOURCE Viking Therapeutics, Inc.

Share this article

STOKE Shoes Welcomes Footwear Industry Veteran Dave Powers as Advisor and Investor

Former Deckers Brands President & CEO and HOKA growth leader joins STOKE as the brand tackles one of footwear's biggest fit problems.

GEORGES MILLS, N.H., Oct. 6, 2026 /PRNewswire/ -- STOKE Shoes, the footwear brand focused on delivering exceptional comfort and fit for everyday wear, today announced that Dave Powers, former President and CEO of Deckers Brands, has joined the company as an advisor and investor.

Powers brings more than four decades of experience building and scaling global footwear and retail businesses, including nearly 13 years at Deckers Brands, where he served as President and CEO from 2016 to 2024. During his tenure, Powers helped lead Deckers through a period of significant growth, including the transformation of HOKA from a niche running brand into a billion-dollar-plus global business. Deckers reported record fiscal 2024 revenue of $4.29 billion under his leadership.

Now, Powers is bringing that experience to Stoke Shoes, a brand addressing a significant but often overlooked problem in footwear: fit.

According to the 2026 Volumental Foot Scan, approximately 76% of men in the U.S. have wide feet, highlighting a significant disconnect between the shape of consumers' feet and the footwear they typically wear. For Stoke, that gap represents an opportunity to rethink how men's footwear is designed around the actual shape of the foot.

"Dave is one of those rare people who has an incredible track record, but is also just a genuinely good dude," said Rick Blackshaw, Co-Founder of Stoke Shoes. "We're incredibly fortunate to have him as an advisor and investor. He knows footwear, he knows how to build brands, and he knows what it takes to scale a business. Even better, there's a personal connection here as CMO Ian Stewart and I first crossed paths with Dave during our time at Converse, so bringing him into STOKE feels like a natural continuation of a relationship that started years ago."

During his time at Deckers, Powers helped create more than $10 billion in shareholder value, while overseeing a period of substantial brand, revenue, and market-capitalization growth. Deckers' own announcement of Powers' retirement credited him with helping build the company into an industry leader and "dramatically increasing shareholder value" during his tenure.

Prior to Deckers, Powers spent four years at Converse, a Nike brand, as Vice President of Global Direct-to-Consumer and Licensed Retail, where he led international DTC expansion and served as part of the Nike retail leadership team. He previously held leadership roles at Timberland and spent a decade at Gap Inc.

"I've spent my career around footwear and STOKE immediately stood out to me because the team is solving a real consumer problem," said Dave Powers. "The opportunity to build a brand around comfort, fit and how people actually live is compelling. I know what it takes to build great footwear brands, and I believe Stoke has the product, the team and the opportunity to do something meaningful in the market. I'm excited to be part of the journey."

As an advisor and investor, Powers will work closely with Stoke's leadership team on brand strategy, product development, retail expansion, distribution and long-term growth.

"Stoke isn't trying to make another shoe and put a logo on it," added Blackshaw. "We're focused on making footwear that actually works for the way people live, and that starts with understanding the foot. Having someone with Dave's experience, perspective and network in our corner gives us an incredible resource as we build the company."

Based in Santa Barbara, Powers holds a B.A. in Marketing from Northeastern University.

About STOKE Shoes

STOKE Shoes is a performance-lifestyle brand engineered for the 97 million all-American men with wide feet overlooked by the athletic footwear industry. Founded by Rick Blackshaw in 2025, Stoke builds shoes that match how real men live; with more room, more cushioning, and more honesty. The company is headquartered in New Hampshire with global manufacturing partners. For more information, visit [www.stokeshoes.com] and follow Stoke Shoes on social media.

Media Contact:

Bethany Willetts | [email protected] 

SOURCE STOKE Shoes

Share this article

Sunshine Retirement Living Announces Successful Sale of Park View Estates

Sale caps a development and management success story built on innovative care programs and a dedicated team

FOUNTAIN VALLEY, Calif., Oct. 6, 2026 /PRNewswire/ -- Sunshine Retirement Living announces the successful sale of Park View Estates, a 150-unit assisted living and memory care community the company developed from the ground up and guided into a thriving senior living destination. The sale closed October 1, 2026, marking a milestone in Sunshine's work across design, entitlement, construction, staffing and operations and the beginning of a new chapter for the community.

Located at 11360 Warner Avenue in Fountain Valley, Park View Estates welcomed its first resident on February 1, 2021. From the first stone through day-to-day management, Sunshine led the community's design and construction, recruited and trained a dedicated team, and implemented innovative assisted living and memory care wellness programs.

Sunshine's approach brought together an inviting residential environment and programs designed to support residents' physical, social, emotional and intellectual well-being. Spanish Colonial Revival architecture, landscaped courtyards and walking paths complemented spaces for fitness, art, entertainment and social connection. Chef-prepared dining and assistance with daily living helped residents enjoy a comfortable, engaging community experience.

In memory care, Sunshine implemented its Hope Blooms approach, grounded in person-centered care and Montessori principles. Meaningful activities, familiar routines and life skills stations connected residents with their interests, past experiences and abilities. Music, sensory experiences and opportunities for purposeful participation supported an environment where residents were celebrated and families were supported.

The employees Sunshine hired and trained were central to bringing that vision to life. In 2024 and 2025, Park View Estates received "Perfect State Survey" and "Deficiency Free" designations through state reviews, underscoring the team's commitment to quality care and operational standards.

Over the past several years, Park View Estates thrived despite challenges affecting senior living operators across the industry, especially in California. Its successful sale reflects Sunshine's ability to carry a community from its initial vision through development and ongoing operations, creating lasting value through its people, programs and management.

"When we began Park View Estates, our vision was to create a place where residents would feel at home and families would feel supported," said Luis Serrano, CEO of Sunshine Retirement Living. "Our team brought that vision to life, from the earliest design decisions to the care and connection residents experienced each day. We are proud of what they accomplished through some challenging years for senior living, and of the strong foundation they built for the community's next chapter."

About Sunshine Retirement Living

Based in Bend, Oregon, Sunshine Retirement Living manages senior living communities throughout the United States, offering senior apartments, independent living, assisted living and memory care. The company focuses on enriching residents' lives through welcoming communities, engaging experiences and programs that promote well-being and social connection. For more information, visit www.sunshineretirementliving.com. 

SOURCE Sunshine Retirement Living

Share this article

Proving mother knows best, Ellen Manning invites 55+ community to join her in playing offense on aging while reclaiming daily energy, using the same Nobel-Prize-winning science powering elite athletes.

The #1 cardiologist-recommended beet brand for heart health that's behind 25+ national championships across Texas Athletics is expanding how Americans of all lifestyles support their cardiovascular health across every stage of life.

AUSTIN, Texas, Oct. 6, 2026 /PRNewswire/ -- Wins over Ohio State come and go, but the science backing your long-term wellness is a high you never come down from. University of Texas quarterback Arch Manning gets so giddy in the presence of a real cardiologist that his mom, Ellen Manning, has to remind him to hustle to the field for the next game. The starstruck encounter kicks off a new national campaign and partnership between the Mannings and Humann, the makers of SuperBeets®, the #1 cardiologist recommended beet brand for heart health support.

Debuting just in time for Allstate Red River Rivalry weekend, the playful spot marks the start of a broader multi-platform collaboration with the Manning family spanning social, digital and community-driven content.

- Head here to watch the hero tailgate spot and access photos.

- Preview additional social shorts where Arch goes head-to-head with his mom and a heart health expert that will roll out over the course of the college football season.

- Visit the microsite to learn more about the initiative and get 20% off at checkout with MANNING20 promo code.

"I put in so much work behind the scenes, which makes me really picky about what I put in my body. Humann has been my daily go-to since playing for UT. It's basically my cheat code for health and performance," says Longhorns quarterback Arch Manning about stepping up his advocacy alongside Humann.

That high standard of performance is backed by pioneering research. Rooted in nitric oxide breakthroughs discovered by Dr. Ferid Murad's program of the University of Texas Health Science Center, Humann products have helped power Texas Athletics' nutrition regimen for over a decade.

For Arch Manning, however, the brand's mission took on a deeper meaning after learning a surprising health reality for moms.

"Taking care of my health is part of being at my best, and cardiovascular health is an important piece of that. Getting to work alongside my mom makes this collaboration even more meaningful and brings together two different stages of life around something that matters to both of us" adds Arch Manning, noting cardiovascular issues run in their family history.

By driving vasodilation (expanding blood vessels to deliver oxygen and nutrients to cells) that same Nobel-Prize-winning science supports everything from a quarterback's athletic endurance to everyday vascular health for his mom.

Science Versus Status Quo

Cardiovascular disease remains the leading cause of death in the U.S., which the CDC links to roughly 1 in every 3 deaths nationwide. Yet, public awareness remains dangerously narrow. People assume it's genetics they can't control, or ignore cardiovascular concerns until something goes wrong.

True cardiovascular wellness isn't just about a single organ. Humann's science-first approach—backed by patents and clinical studies—focuses on the entire 60,000-mile network of blood vessels powering the body, giving people actionable tools to make cardiovascular health part of their daily routines.

"Arch likes to claim his athletic routine, but he really gets his speed from me. Keeping up with my own wellness using SuperBeets Heart Chews is a daily habit now," shares Ellen Manning. "Like a lot of people, I used to think cardiovascular health was strictly about the heart. Learning that it's really about your whole circulatory system—powering your energy, your brain and how your whole body feels every day—was an eye-opener. Getting to share this with Arch and help people realize how easy it is to take better care of themselves means everything."

Claiming Cardiovascular Wellness Control At Every Life Stage

Grounded in good-natured family ribbing between Arch and Ellen, the initiative reframes the body's vascular network as the ultimate engine for total well-being emphasizing how the science serves:

- Healthy Blood Pressure: Supporting blood pressure levels, vascular health and stamina from the training room to everyday life.

- Cellular Energy: Delivering oxygen and vital nutrients to fuel all 36 trillion cells in the body.

- Proactive Wellness: Shifting heart care from a late-in-life task to an active, everyday advantage for all ages.

According to Dr. Christopher Davis, a triple board-certified interventional cardiologist and Chief Cardiologist at Humann featured in the spot with the Manning family, healthcare practitioners have spent decades treating heart issues downstream while completely ignoring the vascular pathways that drive health upstream. "There is truly no such thing as starting too early, and it's never too late to opt in. When we shift our focus to supporting that system daily, it fundamentally changes how people age and feel."

Turning that medical imperative into a cultural shift is the ambition fueling Humann's next chapter.

"Arch calls Humann a cheat code, and honestly, it can feel like one when you experience the difference in your daily energy and stamina at any age. But what's actually happening underneath is no shortcut; it's uncompromising science," says Joel Kocher, Co-Founder and CEO of Humann. "By teaming up with Ellen and Arch, we aren't just amplifying a message. We have a mother-son duo leading a charge to change how whole generations look at longevity. Cardiovascular health isn't a box to check or a late-in-life medical milestone. It's the absolute core foundation for how we live, perform and feel every single day."

MEDIA KIT + CONTACT DETAILS

See our online Media Kit for more downloadable assets, here.

Media Contact: Katie Walley-Wiegert, [email protected] | 573.822.2361

ABOUT HUMANN

Humann is building the new cardiovascular health standard, supporting heart health and overall wellness through science-backed cardiovascular supplementation. Best known for SuperBeets®, the #1 cardiologist recommended beet brand for heart health support, Humann focuses on supporting healthy blood flow to help deliver oxygen and nutrients throughout the body.

Founded through academic and scientific research at The University of Texas, Humann brings clinically studied ingredients and physician-aligned innovation into daily routines. Humann is trusted by more than 2,000 collegiate and professional sports programs and used by thousands of medical practitioners nationwide. Humann's products are available in more than 30,000 retail locations that include Costco, Sam's Club, Walmart, Target, GNC and on humann.com. Follow Humann on LinkedIn, Instagram and Facebook.

SOURCE Humann

Share this article

The latest Thinx innovation combines leakproof protection and everyday wearability in a style designed to move beyond the underwear drawer.

CHICAGO, Oct. 6, 2026 /PRNewswire/ -- Thinx, the #1-selling reusable period underwear brand (based on grocery, drug, mass, & dollar units, 52 weeks thru 9/5/26), today announced the launch of Butterfly Shorts, a new category-bending style that blurs the line between apparel and period care.

For years, period underwear has largely been positioned as an undergarment. Butterfly Shorts challenge that expectation by combining leakproof protection for up to 12 hours with a fluttery, athletic-inspired silhouette designed to be worn as part of an outfit, not hidden beneath one.

Whether heading to a workout, catching a flight, running errands, or simply moving through a busy day, Butterfly Shorts are designed to help consumers spend less time managing their period and more time living their lives.

"At Thinx, we believe periods shouldn't limit what's possible," said Nicole Pawlukowsky, vice president of Thinx. "Thinx has been reimagining period care for over a decade. By bringing trusted Thinx protection to athleisure, we're creating a new way to feel comfortable, confident, and ready for whatever the day brings."

Style Meets Protection

Butterfly Shorts look and feel like everyday athleisure, but behind the design is the trusted protection consumers expect from Thinx.

Butterfly Shorts are leakproof for up to 12 hours, are made with Coolcore™ breathable mesh fabric, and feature an absorbent gusset designed for overnight protection. Available in sizes XS-4X, Butterfly Shorts are made for real life: morning workouts, long travel days, weekend plans, and everything in between.

For consumers who've ever wished period care fit more naturally into their lifestyle, Butterfly Shorts have the answer: dependable protection without sacrificing comfort, movement, or personal style.

Period Care, Reimagined

Butterfly Shorts are the latest example of the brand's commitment to rethinking what's possible in period care.

Building on the success of the Butterfly Shorts style for teens, this new adult offering brings the same combination of protection, comfort, and wearability to a broader audience. The result is a product designed not simply around periods, but around the lives people want to live while having them.

Thinx Butterfly Shorts will be available October 6, 2026 at Thinx.com for $56.

About Kimberly-Clark

Kimberly-Clark (NASDAQ: KMB) and its trusted brands are an indispensable part of life for people in more than 175 countries and territories. Our portfolio of brands, including Huggies, Kleenex, Scott, Kotex, Cottonelle, Poise, Depend, Pull-Ups, Goodnites, Intimus, Plenitud, Sweety, Softex, Viva and WypAll, hold No. 1 or No. 2 share positions in approximately 70 countries. Our company's purpose is to deliver Better Care for a Better World. We are committed to using sustainable practices designed to support a healthy planet, build strong communities, and enable our business to thrive for decades to come.

SOURCE Kimberly-Clark

Share this article

Home energy, as it should be: To address today's rising energy demand and costs, the company is rebranding and expanding from thermostats to a whole-home solution. This approach puts household savings first and aims to create systemwide benefits through the continued growth of virtual power plants (VPPs).

SAN FRANCISCO, Oct. 6, 2026 /PRNewswire/ -- Renew Home, the largest residential virtual power plant (VPP) operator in the U.S., today announced it is changing its name to Everyday Electric and introducing a new, whole-home VPP. The rebrand reflects the company's expansion beyond smart thermostat optimization into a whole-home solution, as rising energy demand and costs make coordinated household savings more important than ever.

"We're at a pivotal moment in energy, similar to what we've seen before with major infrastructure decisions, and the choices we make now will shape the grid for decades," said Ben Brown, CEO of Everyday Electric. "We believe the best path forward starts with better utilizing what we already have, so households can save money and the grid gets the flexible capacity it needs. That belief is what's behind our new name. Everyday Electric is our commitment to building the kind of system we've always believed was possible, one that is more reliable and affordable for everyone."

Addressing today's increasing costs and expectations

For the first time in decades, electricity demand is rising faster than predicted, driven by electrification and new large-load growth, and putting strain on the grid. The default response—which focuses only on building new infrastructure—is expensive, inefficient, and pushes costs onto households. That combination of rising demand and rising costs is what makes this moment different: Without a faster, more cost-efficient approach for adding capacity that doesn't only rely on new infrastructure, households are likely to keep absorbing the difference. Everyday Electric is taking a different approach to meeting demand, focusing first on better utilization that prioritizes household savings.

Based on commissioned research, the company believes the market is ready for this new approach to home energy management and savings. 58% of multi-device owners say their energy bill is getting harder to manage, and 81% of customers want to know how their energy products are saving them money to ensure they are getting the benefits they expect. Everyday Electric aims to meet these expectations directly with integrated savings experiences and the company's virtual power plant, Everyday VPP.

"Saving money and energy at home should be easier," said Jeff Gleeson, Chief Product Officer at Everyday Electric. "We've already seen that when energy use flexes naturally with people's lives, costs can go down and capacity can go up in meaningful ways. Now, we're working toward helping households save over $5 billion in the next five years, and that includes every household our energy provider partners serve, not just homes with smart products."

Building a better future alongside partners and across the home

By better utilizing existing resources, Everyday Electric aims to minimize the immediate need for more expensive, less sustainable infrastructure that would otherwise continue to drive up costs and carbon emissions. The company points to virtual power plants as a more scalable, cost-efficient way to add capacity, and is introducing Everyday VPP, a personalized virtual power plant that builds upon traditional demand response programs. For existing and new energy provider partners, this means:

- OEM-embedded activation: Integrated energy experiences make it easier for customers to turn on savings and rewards features, also reducing the marketing burden on our energy partners.

- Personalized adjustments: Customers participate at the level that fits their life, increasing satisfaction and unlocking more VPP capacity.

- Connected insights: Our new savings link capability helps utilities surface energy insights and savings recommendations right where customers already manage their home energy.

- Whole-home reach: Direct partnerships with HVAC, EV, EVSE, storage, and solar OEMs coordinate these devices into one system, adding up to greater VPP capacity.

- Utility-grade operations: Energy partners get hyper-local dispatch, AMI-based EM&V, real-time forecasting, and load shaping, all built-in at no additional cost.

- Boosted cost effectiveness: Energy partners pay based on resource performance, not platform or marketing fees, lowering program costs and freeing up budget to reward more customers.

Everyday Electric brings its same savings-first principles to an expanding list of OEM partners, integrating savings experiences into people's home energy products and enabling seamless VPP participation.

The company has already proven its approach at scale. Everyday Electric was founded as Renew Home in 2024 by leaders from Google Nest energy and Google AI Labs teams, in partnership with Sidewalk Infrastructure Partners. The team ran customer-centric energy programs for Nest thermostat customers that established a core finding the company is now applying more broadly: Comfort and convenience centric flexibility is what scales, adding up to capacity the size of a fleet of power plants. The company is now aiming to extend that same model beyond HVAC to the rest of the connected home.

Expanding into electric vehicles with a turnkey acquisition

To help accelerate its growth outside of HVAC, Everyday Electric also announced today that it has acquired Smartcar, a connected-vehicle platform that allows drivers to connect their vehicles with energy and mobility companies without additional hardware. The acquisition extends Everyday Electric's energy solutions to include electric vehicles, bringing vehicle connectivity and integrations in-house to support simplified customer savings and managed charging as part of the utility programs the company operates.

Creating reliability and affordability across the grid

As more products in the home unlock savings and provide flexible capacity, Everyday Electric is working toward a system where affordability and reliability compound rather than trade off, lowering costs not just for participating households, but for everyone across the grid.

About Everyday Electric

Everyday Electric provides energy solutions that simplify savings at home and support a stronger grid. Operating the largest residential VPP in the U.S., Everyday Electric coordinates 6+ GW of capacity across connected products, including smart thermostats, electric vehicles, solar, and storage. By taking a whole-home approach that works with daily life, Everyday Electric is helping build a more affordable, more reliable system for everyone. Learn more at everydayelectric.com.

Media Contact

[email protected]

SOURCE Everyday Electric

Share this article

Solidion Technology (NASDAQ: STI) Sees no Basis to Increase Its Offer to Polar Power, Inc. (NASDAQ: POLA) in Response to Board Rejection of All-Cash Asset Acquisition Proposal

Warns Polar Power Shareholders that the Company is "Severely Distressed"

DALLAS, Oct. 6, 2026 /PRNewswire/ -- Solidion Technology, Inc. (NASDAQ: STI) ("Solidion Technology" or "the Company"), an advanced battery technology solutions provider, today reaffirmed its disciplined acquisition strategy and commitment to maximizing shareholder value. Additionally, the Company responded to the decision of the Board of Directors of Polar Power, Inc. (NASDAQ: POLA) ("Polar Power" or "POLA") to reject Solidion's previously submitted all-cash proposal to acquire substantially all of Polar Power's assets.

"Our acquisition proposals are not personal, nor are our valuations meant to diminish the technology, people or opportunities of the companies we evaluate," said Jaymes Winters, Chairman and CEO of Solidion Technology. "Our offers and valuations are the product of disciplined financial modeling, due diligence and our assessment of both the value of the assets and the capital and execution required to realize their potential. We will continue to make offers based on those fundamentals, and we will not overpay to simply complete a transaction."

Winters continues, "Polar Power, Inc. is a severely distressed company who is desperate to raise expensive, dilutive capital in the face of economic headwinds and without adequate downside protection for their own shareholders. This entities' future is in doubt."

In Solidion's opinion, the offer in the previously submitted all-cash asset acquisition does not undervalue Polar Power for the following reasons:

- Polar continues to require additional capital and relies on dilutive financing: On July 27, 2026, Polar established a committed equity facility permitting the sale of up to $25 million of common stock to support working capital. Additionally, Polar Power recently raised capital through convertible securities with conversion prices tied to its market price, including August 26 notes that convert at the lower of 80% of the five-day VWAP or $1.00 per share, if not repaid at maturity, at the expense of existing shareholders.

- Polar continues to generate operating losses and negative cash flow: For the six months ended June 30, 2026, Polar Power reported a net loss of approximately $2.0 million and used approximately $2.2 million of cash in operations resulting in a cash balance of $183,000.

- Polar continues to face NASDAQ compliance issues and going concern doubts: NASDAQ notified Polar on December 31, 2025 that Polar did not satisfy its minimum stockholders' equity requirement after Polar reported approximately $144,000 in stockholders' equity. Polar has until October 28, 2026 to demonstrate compliance. In its June 30, 2026 Form 10-Q, Polar Power's independent registered public accounting firm expressed substantial doubt about Polar's ability to continue as a going concern.

- Recent balance sheet actions do not eliminate the underlying need for operating capital: Polar Power recently converted approximately $614,700 of debt owed to its CEO to preferred equity. Polar said this was an important step toward reaching NASDAQ compliance, however it does not provide the operating liquidity required to fund the business or eliminate the need for additional capital.

Solidion is a strategic acquirer, and it is first and foremost a custodian of shareholder capital. Solidion fully intends to fulfill its fiduciary obligations of maximizing shareholder value, and the Company will continue to value potential acquisition targets and make offers based on disciplined financial modeling. Solidion will not overpay for the companies it seeks to acquire.

As such, Solidion's valuation reflects the realities of a company as deeply distressed as Polar Power, alongside the investment and execution necessary for Solidion to assume following an acquisition.

About Solidion Technology, Inc.

Headquartered in Dallas, Texas with pilot production facilities in Dayton, Ohio, Solidion's (NASDAQ: STI) core business includes manufacturing of battery materials and components, as well as development and production of next-generation batteries for energy storage systems, including UPS systems serving the artificial intelligence (AI) data center market and electric vehicles for ground, aerospace, and sea transportation. Solidion holds a portfolio of over 385 patents, covering innovations such as high-capacity, silane gas free and graphene-enabled silicon anodes, biomass-based graphite, advanced lithium-sulfur and lithium-metal technologies.

For more information, please visit www.solidiontech.com or contact Investor Relations.

Important Information Regarding the Proposed Transaction

Solidion has expressed its interest in pursuing a potential asset acquisition of Polar Power, Inc. No assurance can be given that a definitive agreement will be entered into or that any transaction will ultimately be commenced or consummated. This is not a legally binding obligation, offer, or commitment by either party. No past, present, or future expression of intent, proposal, discussion, or course of conduct shall give rise to any legally binding contract or obligation to proceed with or close the proposed transaction unless and until a definitive written acquisition agreement has been fully executed. Any proposed transaction would be subject to applicable legal and regulatory requirements, the completion of due diligence, financing considerations, required approvals and other customary conditions.

This communication is for informational purposes only and does not constitute an offer to purchase or a solicitation of an offer to sell any securities. Additionally, this communication does not constitute an offer to buy or solicitation of an offer to sell any securities. This communication relates to a proposal which Solidion has made for a business combination transaction with Polar. This communication is not a substitute for any proxy statement, registration statement, tender offer statement, prospectus or other document the parties may file with the SEC in connection with the proposed transaction. This document shall not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. If and when a transaction is commenced, Solidion expects to file applicable materials with the U.S. Securities and Exchange Commission. Investors and security holders are urged to read such materials carefully and in their entirety when and if they become available because they will contain important information.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Solidion Technology Inc., (NASDAQ: STI) (the "Company," "Solidion," "we," "our" or "us") desires to take advantage of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and is including this cautionary statement in connection with this safe harbor legislation. The words "forecasts" "believe," "may," "estimate," "continue," "anticipate," "intend," "should," "plan," "could," "target," "potential," "is likely," "expect" and similar expressions, as they relate to us, are intended to identify forward-looking statements. We undertake no obligation to publicly update any forward-looking statements, whether as a result of new information, future developments or otherwise, except as may be required by law.

Please follow us on:

Share this article

Since its January 2026 debut as the first collaborative home search experience built with MLSs, Realtor.com®+ has seen significant traction, with up to 10% agent adoption in live markets. RealAssist™ AI is designed to deepen that engagement by taking on the repetitive parts of an agent's day, helping them spend less time on manual tasks and more time serving clients.

RealAssist™ AI launches with three core capabilities:

- AI-Driven Client and Search Setup — Guides agents through setting up clients and co-buyers, capturing preferences and notes, and automatically generating more tailored home searches for those clients.

- Daily Digest — Synthesizes a client's activity across chats, searches, notifications and price changes into one Daily Digest summary, with suggested next steps, so agents quickly know and understand what matters most for them.

- Agentic Actions — Recommends actions and helps execute tasks, such as refining home searches based on professional-level MLS data fields or drafting client messages in the agent's own tone – with agents always in the driver's seat, reviewing and approving every action.

"Realtor.com®+ is evolving into a more intelligent agent workspace that helps real estate professionals reduce manual work, respond faster to their clients, and stay in closer sync with buyer activity – and RealAssist™ AI is at the center of that shift," said Anna Marie Castiglioni, Head of Realtor.com® Next. "It transforms the platform from a collaboration center into an agent's proactive partner. It starts by getting them moving faster through client setup, then keeps working in the background surfacing insights, drafting high-intent communications and flagging ready-now opportunities before an agent even logs in."

RealAssist™ AI arrives alongside a broader wave of updates to the platform and growing agent adoption. Realtor.com®+ is expanding its suite of agent-focused tools with updates designed to simplify workflows and strengthen client connections:

- Realtors Property Resource® integration — Brings one of the National Association of Realtors®' highest-value, member-only assets, Realtors Property Resource®, directly into Realtor.com®+ so Realtors® can access property insights, reports, and market intelligence right where they work with clients.

- Public invite link — Allows agents to invite entire groups of buyers to their co-branded collaboration experience with a single custom URL or QR code, helping agents grow their client base while removing the friction of one-by-one manual invitations.

- Listing notes — A persistent place for agents and their connected clients to capture context and thoughts on specific listings.

"Market questions come up constantly in conversations between agents and their clients," said Jeff Young, CEO, Realtors Property Resource®. "Bringing RPR Market Trends into Realtor.com®+ gives Realtors® access to trusted local market data right inside that collaboration experience, helping them add context to those conversations and guide clients with greater confidence."

That expanding toolset is also fueling growth; Realtor.com®+ is now live in 21 markets, with four more markets launching soon, serving more than 192,000 agents nationwide – more than 10% of the U.S. agent market – and spanning nearly 252,000 listings. Among the newest MLSs to launch the platform is Austin, Texas-based Unlock MLS.

"Realtor.com® offers top-of-funnel search behavior, and Unlock MLS offers rich, verified transaction data. Put those two things together in a way that keeps the agent at the center, and you get something truly valuable that neither side can build alone," said Emily Girard, CEO of Unlock MLS. "For a long time, the assumption was that MLSs had to either build every piece of tech ourselves or hand our data over and hope for the best. This is a third path where we bring the expertise nobody else has – what our data actually means, how agents actually behave inside it – and Realtor.com® brings expertise we don't have and shouldn't have to build from scratch."

About Realtor.com®

Realtor.com® pioneered online real estate and has been at the forefront for over 25 years, connecting buyers, sellers, and renters with trusted insights, professional guidance and powerful tools to help them find their perfect home. Recognized as the No. 1 site trusted by real estate professionals, Realtor.com® is a valued partner, delivering consumer connections and a robust suite of marketing tools to support business growth. Realtor.com® is operated by News Corp [Nasdaq: NWS, NWSA] [ASX: NWS, NWSLV] subsidiary Move, Inc.

Media Contact: Sara Wiskerchen, [email protected]

SOURCE Realtor.com

Share this article